Orly Vardeny, PharmD, MS1; KyungMann Kim, PhD2; Jacob A. Udell, MD, MPH3; Jacob Joseph, MD4,5; Akshay S. Desai, MD, MPH5; Michael E. Farkouh, MD, MSc6; Sheila M. Hegde, MD, MPH5; Adrian F. Hernandez, MD7; Allison McGeer, MD, MSc8; H. Keipp Talbot, MD, MPH9; Inder Anand, MD1; Deepak L. Bhatt, MD, MPH5; Christopher P. Cannon, MD5; David DeMets, PhD2; J. Michael Gaziano, MD4,5; Shaun G. Goodman, MD, MSc10; Kristin Nichol, MD, MPH1; Matthew C. Tattersall, DO, MS11; Jonathan L. Temte, MD, PhD12; Janet Wittes, PhD13; Clyde Yancy, MD14; Brian Claggett, PhD15; Yi Chen, MS2; Lu Mao, PhD2; Thomas C. Havighurst, MS2; Lawton S. Cooper, MD, MPH16; Scott D. Solomon, MD5; for the INVESTED Committees and Investigators
doi : 10.1001/jama.2020.23649
JAMA. 2021;325(1):39-49
Influenza is temporally associated with cardiopulmonary morbidity and mortality among those with cardiovascular disease who may mount a less vigorous immune response to vaccination. Higher influenza vaccine dose has been associated with reduced risk of influenza illness.
Xi Wang, MD1; Shu-Sen Wang, MD2; Heng Huang, MD3; Li Cai, MD4; Li Zhao, MD5; Rou-Jun Peng, MD6; Ying Lin, MD7; Jun Tang, MD1; Jian Zeng, MD8; Le-Hong Zhang, MD9; Yong-Li Ke, MD10; Xian-Ming Wang, MD11; Xin-Mei Liu, MD12; Qian-Jun Chen, MD13; An-Qin Zhang, MD14; Fei Xu, MD2; Xi-Wen Bi, MD2; Jia-Jia Huang, MD2; Ji-Bin Li, PhD15; Dan-Mei Pang, MD16; Cong Xue, MD2; Yan-Xia Shi, MD2; Zhen-Yu He, MD17; Huan-Xin Lin, MD17; Xin An, MD2; Wen Xia, MD2; Ye Cao, PhD15; Ying Guo, PhD15; Yan-Hong Su, MD18; Xin Hua, MD2; Xin-Yue Wang, MD2; Ruo-Xi Hong, MD2; Kui-Kui Jiang, MD2; Chen-Ge Song, MD2; Zhang-Zan Huang, MD2; Wei Shi, MD19; Yong-Yi Zhong, MD2; Zhong-Yu Yuan, MD2; for the South China Breast Cancer Group (SCBCG)
doi : 10.1001/jama.2020.23370
JAMA. 2021;325(1):50-58
Among all subtypes of breast cancer, triple-negative breast cancer has a relatively high relapse rate and poor outcome after standard treatment. Effective strategies to reduce the risk of relapse and death are needed.
Francis Couturaud, MD, PhD1,2,3; Laurent Bertoletti, MD, PhD3,4,5; Jean Pastre, MD6,7; Pierre-Marie Roy, MD, PhD3,8,9; Raphael Le Mao, MD1,2,3; Frédéric Gagnadoux, MD, PhD10,11; Nicolas Paleiron, MD, MS12; Jeannot Schmidt, MD3,13,14; Olivier Sanchez, MD, PhD3,6,7; Elodie De Magalhaes, MD3,4,5; Mariam Kamara, MD, MS15; Clément Hoffmann, MD2,16; Luc Bressollette, MD, PhD2,3,16; Michel Nonent, MD, PhD2,17; Cécile Tromeur, MD, PhD1,2,3; Pierre-Yves Salaun, MD, PhD3,18,19; Sophie Barillot, MS20; Florence Gatineau, MS20; Patrick Mismetti, MD, PhD3,4,5; Philippe Girard, MD3,21; Karine Lacut, MD, PhD1,2,3; Catherine A. Lemarié, PhD1,2,3,22; Guy Meyer, MD3,6,23; Christophe Leroyer, MD, PhD1,2,3; for the PEP Investigators
doi : 10.1001/jama.2020.23567
JAMA. 2021;325(1):59-68
The prevalence of pulmonary embolism in patients with chronic obstructive pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain.
Julia Stowe, PhD1; Helen Smith, BSc(Hons)2; Kate Thurland, MPH2; Mary E. Ramsay, MBBS1; Nick Andrews, PhD1; Shamez N. Ladhani, PhD1
doi : 10.1001/jama.2020.21369
JAMA. 2021;325(1):86-87
Sara C. Handley, MD, MSCE1; Anne M. Mullin, BS2; Michal A. Elovitz, MD2; Kristin D. Gerson, MD, PhD2; Diana Montoya-Williams, MD1; Scott A. Lorch, MD, MSCE1; Heather H. Burris, MD, MPH1
doi : 10.1001/jama.2020.20991
JAMA. 2021;325(1):87-89
Nicole Lurie, MD, MSPH1; Bettina Experton, MD, MPH2
doi : 10.1001/jama.2020.22720
JAMA. 2021;325(1):21-22
Valerie Montgomery Rice, MD1
doi : 10.1001/jama.2020.21576
JAMA. 2021;325(1):23-24
Robert Klitzman, MD1
doi : 10.1001/jama.2020.23476
JAMA. 2021;325(1):25-26
Howard Bauchner, MD1
doi : 10.1001/jama.2020.23346
JAMA. 2021;325(1):29-30
Clyde W. Yancy, MD1; Howard Bauchner, MD2
doi : 10.1001/jama.2020.23601
JAMA. 2021;325(1):31-32
Manish M. Patel, MD, MS1; Timothy M. Uyeki, MD, MPH, MPP1
doi : 10.1001/jama.2020.23948
JAMA. 2021;325(1):33-35
Heather A. Parsons, MD, MPH1; Harold J. Burstein, MD, PhD1
doi : 10.1001/jama.2020.23371
JAMA. 2021;325(1):36-38
Kelly Cushing, MD, MSCI1; Peter D. R. Higgins, MD, PhD, MSc1
doi : 10.1001/jama.2020.18936
JAMA. 2021;325(1):69-80
Crohn disease, a chronic gastrointestinal inflammatory disease, is increasing in incidence and prevalence in many parts of the world. Uncontrolled inflammation leads to long-term complications, including fibrotic strictures, enteric fistulae, and intestinal neoplasia. Therefore, early and effective control of inflammation is of critical importance.
AbdulRahman Dia, MD1; Adam S. Cifu, MD1; Atman P. Shah, MD1
doi : 10.1001/jama.2020.22176
JAMA. 2021;325(1):81-82
Myron Zhang, MD1; Shari R. Lipner, MD, PhD1
doi : 10.1001/jama.2020.15176
JAMA. 2021;325(1):83-84
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.22796
JAMA. 2021;325(1):14-16
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.25618
JAMA. 2021;325(1):20
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.24348
JAMA. 2021;325(1):20
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.25620
JAMA. 2021;325(1):20
Lawrence O. Gostin, JD1
doi : 10.1001/jama.2020.23848
JAMA. 2021;325(1):17-18
Tracy Hampton, PhD
doi : 10.1001/jama.2020.24504
JAMA. 2021;325(1):19
Rafael Campo, MA, MD1,2; Elisa New, PhD3,4
doi : 10.1001/jama.2020.24699
JAMA. 2021;325(1):12-13
Kristine E. Ensrud, MD1
doi : 10.1001/jama.2020.2923
JAMA. 2021;325(1):96
Guillaume Mahé, MD, PhD1; Damien Lanéelle, MD2; Alexis Le Faucheur, PhD3
doi : 10.1001/jama.2020.22475
JAMA. 2021;325(1):89
Anurag Mehta, MD1; Laurence S. Sperling, MD1; Bryan J. Wells, MD1
doi : 10.1001/jama.2020.22490
JAMA. 2021;325(1):89-90
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟